• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表皮生长因子受体在人类肺癌进展中作用的证据。

Evidence for a role of EGF receptor in the progression of human lung carcinoma.

作者信息

Pavelic K, Banjac Z, Pavelic J, Spaventi S

机构信息

Department of Molecular Medicine, Ruder Boskovic Institute, Zagreb, Croatia.

出版信息

Anticancer Res. 1993 Jul-Aug;13(4):1133-7.

PMID:8394672
Abstract

Sixty-three primary lung carcinomas were examined immunohistochemically for the presence of epidermal growth factor receptors (EGF-R). Of these tumors 35 (55.5%) were positive for EGF-R. A positive correlation between overexpression of EGF-R, on the one hand, and high metastatic rate, poor tumor differentiation and high rate of tumor proliferation, on the other hand, was found. From one tumor with an extremely high amount of EGF-R a primary cell culture was established. The addition of anti-EGF-R serum to this culture decreased cell proliferation. Our results support the evidence for a positive relationship between overexpression of EGF-R and invasiveness, poor differentiation and high growth rate of tumor cells. The blockade of EGF-R with specific antibodies suppressed tumor cell proliferation, suggesting a role of EGF-R in tumor progression.

摘要

对63例原发性肺癌进行免疫组织化学检查,以检测表皮生长因子受体(EGF-R)的存在情况。在这些肿瘤中,35例(55.5%)EGF-R呈阳性。研究发现,一方面EGF-R的过表达与另一方面的高转移率、肿瘤低分化及高肿瘤增殖率之间存在正相关。从一例EGF-R含量极高的肿瘤中建立了原代细胞培养。向该培养物中添加抗EGF-R血清可降低细胞增殖。我们的结果支持了EGF-R过表达与肿瘤细胞侵袭性、低分化及高生长率之间存在正相关的证据。用特异性抗体阻断EGF-R可抑制肿瘤细胞增殖,提示EGF-R在肿瘤进展中起作用。

相似文献

1
Evidence for a role of EGF receptor in the progression of human lung carcinoma.表皮生长因子受体在人类肺癌进展中作用的证据。
Anticancer Res. 1993 Jul-Aug;13(4):1133-7.
2
Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis.表皮生长因子受体和转化生长因子α在乳头状和非乳头状肾细胞癌中的表达:与转移行为和预后的相关性
Clin Cancer Res. 1995 Aug;1(8):913-20.
3
Human lung cancers growing on extracellular matrix: expression of oncogenes and growth factors.在细胞外基质上生长的人肺癌:癌基因和生长因子的表达
Anticancer Res. 1992 Nov-Dec;12(6B):2191-6.
4
Immunohistochemical detection of epidermal growth factor receptor lacks prognostic significance for breast carcinoma.表皮生长因子受体的免疫组织化学检测对乳腺癌缺乏预后意义。
J Soc Gynecol Investig. 1995 Jul-Aug;2(4):653-9.
5
Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression.表皮生长因子受体及其配体转化生长因子α的过表达在可切除的非小细胞肺癌中很常见,但不能预测肿瘤进展。
Clin Cancer Res. 1997 Apr;3(4):515-22.
6
Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.生长因子在肺鳞状细胞癌及癌前病变中的差异表达
Clin Cancer Res. 2002 Mar;8(3):734-44.
7
Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications.表皮生长因子受体及肿瘤细胞增殖在膀胱癌中的预后价值:治疗意义
Urol Oncol. 2004 Mar-Apr;22(2):93-101. doi: 10.1016/j.urolonc.2004.01.001.
8
p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer.职业性肺癌患者血清中的p53蛋白、表皮生长因子受体及抗p53抗体
Br J Cancer. 1999 Aug;80(12):1987-94. doi: 10.1038/sj.bjc.6690632.
9
EGF-R expression in ductal breast cancer: proliferation and prognostic implications.表皮生长因子受体在乳腺导管癌中的表达:增殖及预后意义
Anticancer Res. 1997 Jan-Feb;17(1B):769-74.
10
Increased estrogen receptor and epidermal growth factor receptor gene product co-expression in surgically resected gastric adenocarcinomas.手术切除的胃腺癌中雌激素受体和表皮生长因子受体基因产物共表达增加。
J Surg Oncol. 1996 Nov;63(3):166-71. doi: 10.1002/(SICI)1096-9098(199611)63:3<166::AID-JSO6>3.0.CO;2-B.

引用本文的文献

1
Comprehensive Kinase Activity Profiling Revealed the Kinase Activity Patterns Associated with the Effects of EGFR Tyrosine Kinase Inhibitor Therapy in Advanced Non-Small-Cell Lung Cancer Patients with Sensitizing EGFR Mutations.全面激酶活性分析揭示了与表皮生长因子受体(EGFR)酪氨酸激酶抑制剂治疗对携带敏感EGFR突变的晚期非小细胞肺癌患者疗效相关的激酶活性模式。
Proteomes. 2023 Feb 5;11(1):6. doi: 10.3390/proteomes11010006.
2
Worldwide Prevalence of Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer: A Meta-Analysis.全球非小细胞肺癌中表皮生长因子受体突变的流行率:一项荟萃分析。
Mol Diagn Ther. 2022 Jan;26(1):7-18. doi: 10.1007/s40291-021-00563-1. Epub 2021 Nov 23.
3
High glucose levels promote the proliferation of breast cancer cells through GTPases.
高血糖水平通过小G蛋白促进乳腺癌细胞的增殖。
Breast Cancer (Dove Med Press). 2017 Jun 13;9:429-436. doi: 10.2147/BCTT.S135665. eCollection 2017.
4
Production and quality control assessment of a GLP-grade immunotoxin, D2C7-(scdsFv)-PE38KDEL, for a phase I/II clinical trial.用于I/II期临床试验的GLP级免疫毒素D2C7-(scdsFv)-PE38KDEL的生产及质量控制评估
Appl Microbiol Biotechnol. 2017 Apr;101(7):2747-2766. doi: 10.1007/s00253-016-8063-x. Epub 2016 Dec 24.
5
Preliminary Evidence on the Diagnostic and Molecular Role of Circulating Soluble EGFR in Non-Small Cell Lung Cancer.循环可溶性表皮生长因子受体在非小细胞肺癌中的诊断及分子作用的初步证据
Int J Mol Sci. 2015 Aug 19;16(8):19612-30. doi: 10.3390/ijms160819612.
6
Epidermal growth factor receptor and AKT1 gene copy numbers by multi-gene fluorescence in situ hybridization impact on prognosis in breast cancer.通过多基因荧光原位杂交检测表皮生长因子受体和AKT1基因拷贝数对乳腺癌预后的影响。
Cancer Sci. 2015 May;106(5):642-9. doi: 10.1111/cas.12637. Epub 2015 Mar 16.
7
Pilot study of a novel combination of two therapeutic vaccines in advanced non-small-cell lung cancer patients.一项新型联合治疗性疫苗在晚期非小细胞肺癌患者中应用的初步研究。
Cancer Immunol Immunother. 2014 Jul;63(7):737-47. doi: 10.1007/s00262-014-1552-9. Epub 2014 Apr 29.
8
Effect of chemotherapy on quality of life in patients with non-small cell lung cancer.化疗对非小细胞肺癌患者生活质量的影响。
Support Care Cancer. 2014 May;22(5):1417-28. doi: 10.1007/s00520-014-2148-9. Epub 2014 Feb 22.
9
Gefitinib versus placebo in completely resected non-small-cell lung cancer: results of the NCIC CTG BR19 study.吉非替尼对比安慰剂用于完全切除的非小细胞肺癌:NCIC CTG BR19 研究结果。
J Clin Oncol. 2013 Sep 20;31(27):3320-6. doi: 10.1200/JCO.2013.51.1816. Epub 2013 Aug 26.
10
Macroporous hydrogel micropillars for quantifying Met kinase activity in cancer cell lysates.用于定量测定癌细胞裂解物中 Met 激酶活性的大孔水凝胶微柱。
Analyst. 2012 Sep 7;137(17):4052-61. doi: 10.1039/c2an35464k. Epub 2012 Jul 20.